Impact of Professional Societies' Recommendations on Practical Use of Hormone Replacement Therapy
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01487304 |
Recruitment Status
:
Completed
First Posted
: December 7, 2011
Last Update Posted
: October 17, 2016
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment |
---|---|
Menopause Hormone Replacement Therapy, Post-Menopausal | Drug: Marketed low dose hormone replacement therapy |
Study Type : | Observational |
Actual Enrollment : | 3760 participants |
Observational Model: | Cohort |
Time Perspective: | Prospective |
Official Title: | Impact of Professional Societies Recommendations on Practical Use of Hormone Replacement Therapy - Project "WOMAN 2005" |
Study Start Date : | April 2005 |
Actual Primary Completion Date : | June 2006 |
Actual Study Completion Date : | June 2006 |
Group/Cohort | Intervention/treatment |
---|---|
Low dose HRT |
Drug: Marketed low dose hormone replacement therapy
A low dose of marketed HRT products prescribed at the discretion of the treating physician
|
- Breast tenderness
- Patient treatment satisfaction after switch to low dose HRT

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | Child, Adult, Senior |
Sexes Eligible for Study: | Female |
Accepts Healthy Volunteers: | No |
Sampling Method: | Probability Sample |
Inclusion Criteria:
- Post-menopausal

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01487304
Czech Republic | |
Novo Nordisk Investigational Site | |
Prague, Czech Republic |
Study Director: | Global Clinical Registry (GCR, 1452) | Novo Nordisk A/S |
Additional Information:
Responsible Party: | Novo Nordisk A/S |
ClinicalTrials.gov Identifier: | NCT01487304 History of Changes |
Other Study ID Numbers: |
KLIM-1937 |
First Posted: | December 7, 2011 Key Record Dates |
Last Update Posted: | October 17, 2016 |
Last Verified: | October 2016 |
Additional relevant MeSH terms:
Hormones Hormones, Hormone Substitutes, and Hormone Antagonists Physiological Effects of Drugs |